peoplePerson
Pawel Kalinski
Pawel Kalinski is an immunologist reprogramming tumour microenvironments so T cells can enter.
Develops chemokine-modulating regimens (interferon, TLR3 agonists, COX-2 inhibition) and dendritic cell vaccines to convert immune-excluded tumours.
Role
Vice Chair for Translational Research, Department of Medicine; Chief, Translational Immuno-Oncology
Institution
Specialisms
Dendritic cell vaccinesChemokine modulationTumour microenvironment
Profiles
| Title | Journal | Year |
|---|---|---|
| Chemokine modulation to enhance T cell infiltration of tumors | Cancer Immunology Research | 2019 |